1 |
10% metronidazole ointment |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
096 1件: 96 💬 |
2 |
11c-flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
206 1件: 206 💬 |
3 |
1500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
4 |
18f-ro6958948 |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
5 |
250mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
6 |
500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
7 |
750mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
8 |
[11c]flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 1件: 13 💬 |
9 |
[18f]flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
206 1件: 206 💬 |
10 |
Act-050089 (ro 61-0612) |
- |
- |
- |
- |
086 1件: 86 💬 |
11 |
Amoxicillin, metronidazole and tetracycline |
Amoxicillin |
7件: D00201 D00201, D00229 D00229, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
097 1件: 97 💬 |
12 |
Azathioprine or mesalazine |
Azathioprine |
3件: D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
13 |
Azithromycin + metronidazole |
Azithromycin |
6件: D00409 D00409, D02134 D02134, D05016 D05016, D05017 D05017, D06390 D06390, D07486 D07486 💬 |
- |
- |
096 1件: 96 💬 |
14 |
Behavioral: role of dopamine |
Dopamine |
2件: D00633 D00633, D07870 D07870 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
15 |
Benznidazole |
Benznidazole |
1件: D02489 D02489 💬 |
- |
- |
065 1件: 65 💬 |
16 |
Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) |
Digoxin |
13件: D00298 D00298, D00330 D00330, D00455 D00455, D00529 D00529, D00550 D00550, D00696 D00696, D01207 D01207, D01475 D01475, D02290 D02290, D05028 D05028, D05259 D05259, D05261 D05261, D08229 D08229 💬 |
ATP1A1 25件: ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 |
Adrenergic signaling in cardiomyocytes 49件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
17 |
Bms-986089-01 (ro7239361) , anti-myostatin |
- |
- |
- |
- |
113 1件: 113 💬 |
18 |
Bms-986089-01 (ro7239361) injections, 15 mg/syringe (21.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
19 |
Bms-986089-01 (ro7239361) injections, 35 mg/syringe (50 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
20 |
Bms-986089-01 (ro7239361) injections, 50 mg/syringe (71.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
21 |
Bms-986089-01 (ro7239361) injections, 7.5 mg/syringe (10.7 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
22 |
Bms-986089-01 (ro7239361), anti-myostatin |
- |
- |
- |
- |
113 1件: 113 💬 |
23 |
Butyrate enemas + routine management |
Butyric Acid |
1件: D05866 D05866 💬 |
- |
- |
291 1件: 291 💬 |
24 |
C5 inh mab, sky59, ro/ch7092230 |
- |
- |
- |
- |
062 1件: 62 💬 |
25 |
Calcitriol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 8件: 37, 46, 49, 66, 96, 158, 235, 326 💬 |
26 |
Calcitriol & calcium |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
27 |
Calcium rosuvastatin |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 1件: 79 💬 |
28 |
Ceftriaxone |
Ceftriaxone |
2件: D00924 D00924, D07659 D07659 💬 |
- |
- |
002 3件: 2 , 6 , 97 💬 |
29 |
Crestor tablets (calcium rosuvastatin) film-coated tablets |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 1件: 79 💬 |
30 |
Delayed and extended release mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
31 |
Delayed release 6mp or calcitriol vs. purinethol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
32 |
Dexmedetomidine with ropivacaine |
Dexmedetomidine |
4件: D00514 D00514, D01205 D01205, D04048 D04048, D08490 D08490 💬 |
ADRA2A 8件: ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway |
070 1件: 70 💬 |
33 |
Diagnostic test: [18f]-ro6958948 |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
34 |
Diagnostic test: elecsys (roche) abeta42, ttau and ptau |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
35 |
Diagnostic test: pet with [11c]flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 1件: 13 💬 |
36 |
Diagnostic test: rey-osterrieth complex figure test (rocft) |
- |
- |
- |
- |
006 1件: 6 💬 |
37 |
Diagnostic test: rotational thromboelastometry |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
38 |
Dopamine agonists (pramipexole, ropirinole) |
Dopamine |
4件: D00559 D00559, D00633 D00633, D05575 D05575, D07870 D07870 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
39 |
Emicizumab (ace910, ro5534262) |
Emicizumab |
1件: D10821 D10821 💬 |
F10 2件: F10, F9 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
288 1件: 288 💬 |
40 |
Eu-approved roactemra |
- |
- |
- |
- |
046 1件: 46 💬 |
41 |
Flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 5件: 6 , 13, 17, 18, 206 💬 |
42 |
Flurbiprofen |
Flurbiprofen |
3件: D00330 D00330, D01475 D01475, D02290 D02290 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 3件: 13, 21, 46 💬 |
43 |
Gamma-secretase/notch signalling pathway inhibitor ro4929097 |
- |
- |
- |
- |
074 1件: 74 💬 |
44 |
Gdc-0853 ro7010939 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
45 |
Glycyrrhiza glabra root |
Glycyrrhiza glabra |
- |
- |
- |
097 1件: 97 💬 |
46 |
Herbal medicinal mixture (roucongrong, heshouwu etc.) |
Reynoutria multiflora root |
- |
- |
- |
006 1件: 6 💬 |
47 |
Hp-3000 (ropinirole hydrochloride patch) |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
48 |
Hp-3000(ropinirole hydrochloride patch) |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
49 |
Humira 40 mg injekcní roztok v predplnené injekcní stríkacce |
- |
- |
- |
- |
096 1件: 96 💬 |
50 |
Hydrocortisone roussel |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
083 1件: 83 💬 |
51 |
Idec-c2b8, ro 45-2294 |
- |
- |
- |
- |
064 1件: 64 💬 |
52 |
Liberase enzyme (roche) |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
53 |
Ly03003 ( rotigotine, extended-release microspheres) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
54 |
Ly03003 (rotigotine extended release microspheres for intramuscular [im] injection) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
55 |
Ly03003( the name of rotigotine) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
56 |
Ly03003(rotigotine,extended-release microspheres) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
57 |
Magnesium with ropivacaine |
Magnesium |
2件: D04048 D04048, D08490 D08490 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 1件: 70 💬 |
58 |
Mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
046 3件: 46, 96, 97 💬 |
59 |
Mesalazine (3,600 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
60 |
Mesalazine (asacol®) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
61 |
Mesalazine (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
62 |
Mesalazine - tid 1000 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
63 |
Mesalazine - tid 2x 500 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
64 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
65 |
Mesalazine 250mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
66 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
2件: D00377 D00377, D02486 D02486 💬 |
- |
- |
097 1件: 97 💬 |
67 |
Mesalazine 4g enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
68 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
69 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
70 |
Mesalazine ec 500 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
71 |
Mesalazine enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
72 |
Mesalazine liquid enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
73 |
Mesalazine slow-release granules |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
74 |
Mesalazine sustained-release tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
75 |
Mesalazine tablet |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
76 |
Mesalazine tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
77 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
2件: D00088 D00088, D00377 D00377 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
78 |
Mesalazine, tripterygium glycosides |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
79 |
Metronidazole |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 8件: 46, 51, 63, 94, 95, 96, 97, 291 💬 |
80 |
Metronidazole capsule 50 mg |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
097 1件: 97 💬 |
81 |
Minoxidil |
Minoxidil |
1件: D00418 D00418 💬 |
ABCC8 2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
179 1件: 179 💬 |
82 |
Mmx mesalamine/ mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
83 |
Mmx mesalamine/mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
84 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
85 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
86 |
Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142 |
BMS-986142 |
11件: D00298 D00298, D00330 D00330, D00529 D00529, D00550 D00550, D00696 D00696, D00893 D00893, D01475 D01475, D02290 D02290, D05028 D05028, D08229 D08229, D08410 D08410 💬 |
ATP1A1 24件: ATP1A1, ATP1A2, ATP1A3, ATP1A4, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HMGCR, PTGS1, PTGS2 💬 |
AMPK signaling pathway 49件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
87 |
Oral roflumilast |
Roflumilast |
1件: D05744 D05744 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
299 1件: 299 💬 |
88 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
3件: D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
89 |
Other: mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
90 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
3件: D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
91 |
Other: rosemary essential oil |
Rosemary |
- |
- |
- |
051 1件: 51 💬 |
92 |
Other: rotigotine |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
93 |
Other: routine |
- |
- |
- |
- |
240 1件: 240 💬 |
94 |
Other: routine management |
- |
- |
- |
- |
291 1件: 291 💬 |
95 |
Other: routine therapy |
- |
- |
- |
- |
299 1件: 299 💬 |
96 |
Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. |
- |
- |
- |
- |
215 1件: 215 💬 |
97 |
Overencapsulated mesalazine tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
98 |
Pet with 11c-flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 1件: 13 💬 |
99 |
Pramipexole or ropinirole |
Pramipexole |
4件: D00559 D00559, D00784 D00784, D05575 D05575, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
100 |
Pro145223 (ro5490261) |
- |
- |
- |
- |
097 1件: 97 💬 |
101 |
Procedure: routine drainage surgery |
- |
- |
- |
- |
096 1件: 96 💬 |
102 |
Pzn 8881655(rochepharma ag) |
- |
- |
- |
- |
085 1件: 85 💬 |
103 |
R-roscovitine |
Seliciclib |
- |
- |
- |
075 1件: 75 💬 |
104 |
Rad001 round tablets |
- |
- |
- |
- |
158 1件: 158 💬 |
105 |
Ramelteon |
Ramelteon |
1件: D02689 D02689 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 3件: 6 , 8 , 46 💬 |
106 |
Rapamycin-calcitriol combination |
Calcitriol |
2件: D00129 D00129, D00753 D00753 💬 |
MTOR 2件: MTOR, VDR 💬 |
AMPK signaling pathway 54件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway |
158 1件: 158 💬 |
107 |
Recombinant human growth hormone + rosiglitazone |
Rosiglitazone |
3件: D00596 D00596, D02691 D02691, D08491 D08491 💬 |
GHR 2件: GHR, PPARG 💬 |
AMPK signaling pathway 14件: AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
265 1件: 265 💬 |
108 |
Riluzole oral soluble film (rosf) 50 mg |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 1件: 2 💬 |
109 |
Ro |
- |
- |
- |
- |
006 1件: 6 💬 |
110 |
Ro 001-9265 |
- |
- |
- |
- |
041 1件: 41 💬 |
111 |
Ro 001-9265/f02 |
- |
- |
- |
- |
041 1件: 41 💬 |
112 |
Ro 001-9265/f02-01 |
- |
- |
- |
- |
046 1件: 46 💬 |
113 |
Ro 001-9265/f03 |
- |
- |
- |
- |
041 1件: 41 💬 |
114 |
Ro 001-9265/f04 |
- |
- |
- |
- |
041 1件: 41 💬 |
115 |
Ro 002-9893/f02 |
- |
- |
- |
- |
046 1件: 46 💬 |
116 |
Ro 106-1443 |
- |
- |
- |
- |
049 1件: 49 💬 |
117 |
Ro 45-2294 |
- |
- |
- |
- |
046 1件: 46 💬 |
118 |
Ro 47-0203 |
- |
- |
- |
- |
051 4件: 51, 85, 86, 88 💬 |
119 |
Ro 47-0203 / act-050088 |
- |
- |
- |
- |
086 1件: 86 💬 |
120 |
Ro 48-77533 |
- |
- |
- |
- |
046 1件: 46 💬 |
121 |
Ro 487-533/f01 |
- |
- |
- |
- |
271 1件: 271 💬 |
122 |
Ro 487-5733/f01 |
- |
- |
- |
- |
271 1件: 271 💬 |
123 |
Ro 487-7533 |
- |
- |
- |
- |
046 1件: 46 💬 |
124 |
Ro 487-7533/f01 |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
125 |
Ro 487-7533/f10 |
- |
- |
- |
- |
046 1件: 46 💬 |
126 |
Ro 487-7533/f10-02 |
- |
- |
- |
- |
046 1件: 46 💬 |
127 |
Ro 487-7533/f10-04 |
- |
- |
- |
- |
041 4件: 41, 46, 51, 107 💬 |
128 |
Ro 491-7523/f18 |
- |
- |
- |
- |
206 1件: 206 💬 |
129 |
Ro 491-7523/f19 |
- |
- |
- |
- |
206 1件: 206 💬 |
130 |
Ro 496-4913 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
131 |
Ro 496-4913/f03 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
132 |
Ro 496-4913/f07 |
- |
- |
- |
- |
013 1件: 13 💬 |
133 |
Ro 549-0261/f04 |
- |
- |
- |
- |
097 1件: 97 💬 |
134 |
Ro 549-0261/f04-02 |
- |
- |
- |
- |
096 1件: 96 💬 |
135 |
Ro 549-0261/f08-02 |
- |
- |
- |
- |
096 1件: 96 💬 |
136 |
Ro 551-6922 |
- |
- |
- |
- |
046 1件: 46 💬 |
137 |
Ro 723-4292/f02 |
- |
- |
- |
- |
008 1件: 8 💬 |
138 |
Ro actemra |
- |
- |
- |
- |
046 1件: 46 💬 |
139 |
Ro-47-0203 |
- |
- |
- |
- |
086 1件: 86 💬 |
140 |
Ro-47-0203/029 |
- |
- |
- |
- |
086 1件: 86 💬 |
141 |
Ro-496-4913 |
- |
- |
- |
- |
046 1件: 46 💬 |
142 |
Ro-actemra |
- |
- |
- |
- |
046 1件: 46 💬 |
143 |
Ro001-9265/f04 |
- |
- |
- |
- |
046 1件: 46 💬 |
144 |
Ro0029893 |
- |
- |
- |
- |
046 1件: 46 💬 |
145 |
Ro0220912 |
- |
- |
- |
- |
085 1件: 85 💬 |
146 |
Ro0280296 |
- |
- |
- |
- |
085 1件: 85 💬 |
147 |
Ro045-2294 |
- |
- |
- |
- |
046 1件: 46 💬 |
148 |
Ro0452294/v01 |
- |
- |
- |
- |
043 2件: 43, 44 💬 |
149 |
Ro0452294/v02 |
- |
- |
- |
- |
035 3件: 35, 43, 44 💬 |
150 |
Ro04877533 |
- |
- |
- |
- |
046 1件: 46 💬 |
151 |
Ro04877533/f05/f04 |
- |
- |
- |
- |
046 1件: 46 💬 |
152 |
Ro0506997 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
153 |
Ro106-1443 |
- |
- |
- |
- |
043 1件: 43 💬 |
154 |
Ro1061443/f02 |
- |
- |
- |
- |
035 1件: 35 💬 |
155 |
Ro3300074 |
- |
- |
- |
- |
231 1件: 231 💬 |
156 |
Ro4402257 |
- |
- |
- |
- |
046 1件: 46 💬 |
157 |
Ro45-2294 |
- |
- |
- |
- |
271 1件: 271 💬 |
158 |
Ro452294/v02 |
- |
- |
- |
- |
046 1件: 46 💬 |
159 |
Ro47-0203 |
- |
- |
- |
- |
086 1件: 86 💬 |
160 |
Ro47-0203 / act-050088 |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
161 |
Ro487-7533 |
- |
- |
- |
- |
046 1件: 46 💬 |
162 |
Ro487-7533/f01-f05 |
- |
- |
- |
- |
046 1件: 46 💬 |
163 |
Ro487-7533/f10-04 |
- |
- |
- |
- |
046 2件: 46, 51 💬 |
164 |
Ro4877533 |
- |
- |
- |
- |
046 1件: 46 💬 |
165 |
Ro4877533 (tcz) |
- |
- |
- |
- |
046 2件: 46, 107 💬 |
166 |
Ro4877533/f01 |
- |
- |
- |
- |
046 1件: 46 💬 |
167 |
Ro4877533/f04-f05 |
- |
- |
- |
- |
046 1件: 46 💬 |
168 |
Ro4917523 |
- |
- |
- |
- |
206 1件: 206 💬 |
169 |
Ro4917523 0.5 mg |
- |
- |
- |
- |
206 1件: 206 💬 |
170 |
Ro4917523 1.5 mg |
- |
- |
- |
- |
206 1件: 206 💬 |
171 |
Ro496-4913 |
- |
- |
- |
- |
046 1件: 46 💬 |
172 |
Ro4964913 |
- |
- |
- |
- |
013 1件: 13 💬 |
173 |
Ro4964913 f07 |
- |
- |
- |
- |
013 1件: 13 💬 |
174 |
Ro4964913/f03 |
- |
- |
- |
- |
013 1件: 13 💬 |
175 |
Ro4964913/f07 |
- |
- |
- |
- |
013 1件: 13 💬 |
176 |
Ro4964913/f07-01 |
- |
- |
- |
- |
013 1件: 13 💬 |
177 |
Ro4964913/f07-01 (commercial) |
- |
- |
- |
- |
013 1件: 13 💬 |
178 |
Ro4964913/f07-01 (development) |
- |
- |
- |
- |
013 1件: 13 💬 |
179 |
Ro5333787 |
- |
- |
- |
- |
013 1件: 13 💬 |
180 |
Ro545-9072/f03 |
- |
- |
- |
- |
053 1件: 53 💬 |
181 |
Ro5459072 |
- |
- |
- |
- |
053 1件: 53 💬 |
182 |
Ro5490255 |
- |
- |
- |
- |
085 1件: 85 💬 |
183 |
Ro5490255/f01-02 |
- |
- |
- |
- |
085 1件: 85 💬 |
184 |
Ro5490261 / f02 |
- |
- |
- |
- |
097 1件: 97 💬 |
185 |
Ro5490261/f02 |
- |
- |
- |
- |
097 1件: 97 💬 |
186 |
Ro5490261/f04-02 |
- |
- |
- |
- |
097 1件: 97 💬 |
187 |
Ro6885247 |
- |
- |
- |
- |
003 1件: 3 💬 |
188 |
Ro6885247/f02 |
- |
- |
- |
- |
003 1件: 3 💬 |
189 |
Ro6885247/f03 |
- |
- |
- |
- |
003 1件: 3 💬 |
190 |
Ro7010939 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
191 |
Ro7010939/f13 |
- |
- |
- |
- |
049 1件: 49 💬 |
192 |
Ro7034067 |
- |
- |
- |
- |
003 1件: 3 💬 |
193 |
Ro7034067 / f12 |
- |
- |
- |
- |
003 1件: 3 💬 |
194 |
Ro7034067 / f13 |
- |
- |
- |
- |
003 1件: 3 💬 |
195 |
Ro7034067/f06 + solvente (ro |
- |
- |
- |
- |
003 1件: 3 💬 |
196 |
Ro7034067/f06 with solvent (ro7034067/f08) |
- |
- |
- |
- |
003 1件: 3 💬 |
197 |
Ro7034067/f07 + solvente (ro |
- |
- |
- |
- |
003 1件: 3 💬 |
198 |
Ro7034067/f07 with solvent (ro7034067/f09) |
- |
- |
- |
- |
003 1件: 3 💬 |
199 |
Ro7034067/f12 |
- |
- |
- |
- |
003 1件: 3 💬 |
200 |
Ro7034067/f13 |
- |
- |
- |
- |
003 1件: 3 💬 |
201 |
Ro7046015 |
- |
- |
- |
- |
006 1件: 6 💬 |
202 |
Ro7049665 |
- |
- |
- |
- |
097 1件: 97 💬 |
203 |
Ro7090919 |
- |
- |
- |
- |
003 1件: 3 💬 |
204 |
Ro7112689 |
- |
- |
- |
- |
062 1件: 62 💬 |
205 |
Ro7112689/f01 |
- |
- |
- |
- |
062 1件: 62 💬 |
206 |
Ro7112689/f03-01 |
- |
- |
- |
- |
062 1件: 62 💬 |
207 |
Ro7112689/f03-03 |
- |
- |
- |
- |
062 1件: 62 💬 |
208 |
Ro7123520 |
- |
- |
- |
- |
046 1件: 46 💬 |
209 |
Ro7123520/f03-01 |
- |
- |
- |
- |
046 1件: 46 💬 |
210 |
Ro7234292 |
- |
- |
- |
- |
008 1件: 8 💬 |
211 |
Ro7234292 (rg6042) |
- |
- |
- |
- |
008 1件: 8 💬 |
212 |
Ro7239361 |
- |
- |
- |
- |
113 1件: 113 💬 |
213 |
Ro7239361 (bms-986089) |
- |
- |
- |
- |
113 1件: 113 💬 |
214 |
Ro7239361 injections, 15 mg/syringe (21.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
215 |
Ro7239361 injections, 35 mg/syringe (50 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
216 |
Ro7239361 injections, 50 mg/syringe (71.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
217 |
Ro7239361 injections, 7.5 mg/syringe (10.7 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
218 |
Ro7246311 |
- |
- |
- |
- |
097 1件: 97 💬 |
219 |
Ro7248824 |
- |
- |
- |
- |
201 1件: 201 💬 |
220 |
Ro7248824/f02-01 |
- |
- |
- |
- |
201 1件: 201 💬 |
221 |
Ro7248824/f03-01 (diluent for ro7248824/f02-01 |
- |
- |
- |
- |
201 1件: 201 💬 |
222 |
Roactemra |
- |
- |
- |
- |
040 9件: 40, 41, 46, 51, 86, 107, 266, 271, 331 💬 |
223 |
Roactemra (r) |
- |
- |
- |
- |
046 1件: 46 💬 |
224 |
Roactemra 162 mg |
- |
- |
- |
- |
046 2件: 46, 51 💬 |
225 |
Roactemra 162 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
041 1件: 41 💬 |
226 |
Roactemra 162 mg solution injectable en seringue préremplie |
- |
- |
- |
- |
046 1件: 46 💬 |
227 |
Roactemra 20 mg/ml concentrado para solución para perfusión |
- |
- |
- |
- |
046 1件: 46 💬 |
228 |
Roactemra 20 mg/ml concentrate for solution for infusion |
- |
- |
- |
- |
046 1件: 46 💬 |
229 |
Roactemra 20 mg/ml concentrate for solution for infusion. |
- |
- |
- |
- |
046 1件: 46 💬 |
230 |
Roactemra 20 mg/ml, concentrado para solución para perfusión |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
231 |
Roactemra 20mg/ml |
- |
- |
- |
- |
040 1件: 40 💬 |
232 |
Roactemra(r) |
- |
- |
- |
- |
046 1件: 46 💬 |
233 |
Roactemra® |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
234 |
Roactemra® 20mg/ml konzentrat |
- |
- |
- |
- |
266 1件: 266 💬 |
235 |
Roactemra®ev product code: prd82321 |
- |
- |
- |
- |
046 1件: 46 💬 |
236 |
Roacterma |
- |
- |
- |
- |
046 1件: 46 💬 |
237 |
Roactmera |
- |
- |
- |
- |
046 1件: 46 💬 |
238 |
Rob 803 |
- |
- |
- |
- |
046 1件: 46 💬 |
239 |
Rob 803 (9-chloro-2,3-dimethyl-6-(n,n-dimethylaminoethylamino-2-oxoethyl)-6h-indolo[2,3-b] quinoxali |
- |
- |
- |
- |
046 1件: 46 💬 |
240 |
Rob 803 (capsules 12.5 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
241 |
Rob 803 (capsules 15 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
242 |
Rob 803 (capsules 25 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
243 |
Rob 803 (capsules 6.25 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
244 |
Rob 803 12.5mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
245 |
Rob 803 15mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
246 |
Rob 803 25mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
247 |
Rob 803 6.25mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
248 |
Rob 803 6.5mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
249 |
Rocuronium |
Rocuronium |
1件: D00765 D00765 💬 |
CHRM1 16件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4 💬 |
Alzheimer disease 15件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
296 1件: 296 💬 |
250 |
Rofecoxib |
Rofecoxib |
1件: D00568 D00568 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
251 |
Roferon-a |
- |
- |
- |
- |
056 1件: 56 💬 |
252 |
Roferon-a 3miu |
- |
- |
- |
- |
056 1件: 56 💬 |
253 |
Roferon-a, 3miu |
- |
- |
- |
- |
056 1件: 56 💬 |
254 |
Roferon-a, 4.5miu |
- |
- |
- |
- |
056 1件: 56 💬 |
255 |
Roferon-a, 6miu |
- |
- |
- |
- |
056 1件: 56 💬 |
256 |
Roflumilast |
Roflumilast |
1件: D05744 D05744 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
084 2件: 84, 299 💬 |
257 |
Roflumilast oral tablet |
Roflumilast |
1件: D05744 D05744 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
299 1件: 299 💬 |
258 |
Rokan (r) novo 120 mg |
- |
- |
- |
- |
018 1件: 18 💬 |
259 |
Rolipram |
Rolipram |
1件: D01783 D01783 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
008 2件: 8 , 13 💬 |
260 |
Romiplostim |
Romiplostim |
1件: D08990 D08990 💬 |
MPL 1件: MPL 💬 |
Cytokine-cytokine receptor interaction 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway |
060 4件: 60, 63, 64, 65 💬 |
261 |
Romiplostin |
- |
- |
- |
- |
063 1件: 63 💬 |
262 |
Romosozumab |
Romosozumab |
1件: D10156 D10156 💬 |
SOST 1件: SOST 💬 |
Parathyroid hormone synthesis, secretion and action 2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway |
046 2件: 46, 274 💬 |
263 |
Rontalizumab |
Rontalizumab |
1件: D09662 D09662 💬 |
IFNA1 13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease 23件: Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 1件: 49 💬 |
264 |
Rop |
- |
- |
- |
- |
006 1件: 6 💬 |
265 |
Rop+l-dopa |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
266 |
Ropinirole |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 3件: 6 , 74, 309 💬 |
267 |
Ropinirole (as hydrochloride) |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
268 |
Ropinirole controlled-release (requip cr) for rls |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
269 |
Ropinirole cr 2mg tablet |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
270 |
Ropinirole cr 8mg tablet |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
271 |
Ropinirole hydrochloride |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 2件: 6 , 309 💬 |
272 |
Ropinirole hydrochloride extended-release tablet |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
273 |
Ropinirole hydrochloride extended-release tablet placebo |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
274 |
Ropinirole hydrochloride prolonged release |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
275 |
Ropinirole immediate release |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
276 |
Ropinirole implant |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
277 |
Ropinirole ir |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
278 |
Ropinirole ir tablets |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
279 |
Ropinirole monotherapy |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
280 |
Ropinirole oral product |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
281 |
Ropinirole pr |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
282 |
Ropinirole pr, 2mg |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
283 |
Ropinirole pr/xr |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
284 |
Ropinirole pr/xr tablets |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
285 |
Ropinirole prolonged release |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
286 |
Ropinirole prolonged release/extended release(pr/xr) |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
287 |
Ropinirole xl |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
288 |
Ropinirole xl (formerly cr) |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
289 |
Ropinirole/l-dopa |
Levodopa |
3件: D00059 D00059, D00784 D00784, D08489 D08489 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
290 |
Ropivacaine |
Ropivacaine |
2件: D04048 D04048, D08490 D08490 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
036 3件: 36, 46, 70 💬 |
291 |
Ropivacaine plus normal saline |
Ropivacaine |
2件: D04048 D04048, D08490 D08490 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 1件: 70 💬 |
292 |
Roscovitine |
- |
- |
- |
- |
299 1件: 299 💬 |
293 |
Rosemary |
Rosemary |
- |
- |
- |
051 1件: 51 💬 |
294 |
Rosiglitazone |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 5件: 46, 75, 97, 222, 265 💬 |
295 |
Rosiglitazone (avandia) |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
222 1件: 222 💬 |
296 |
Rosiglitazone extended release tablets |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
297 |
Rosiglitazone maleate |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 3件: 46, 75, 265 💬 |
298 |
Rosiglitazone xr |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
299 |
Rosuvastatin |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
300 |
Rosuvastatin 10 mg |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
096 1件: 96 💬 |
301 |
Rosuvastatin 20mg |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 1件: 79 💬 |
302 |
Rosuvastatin calcium |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
049 4件: 49, 79, 97, 299 💬 |
303 |
Rosuvastatin calcium 40mg |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
056 1件: 56 💬 |
304 |
Rosuvastatine eg |
- |
- |
- |
- |
097 1件: 97 💬 |
305 |
Rotigotin |
- |
- |
- |
- |
006 1件: 6 💬 |
306 |
Rotigotina |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
307 |
Rotigotine |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
308 |
Rotigotine (reference product pr 2.1.1) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
309 |
Rotigotine (test product pr 2.3.1) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
310 |
Rotigotine hydrochloride |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
311 |
Rotigotine nasal spray |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
312 |
Rotigotine transdermal patch |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
313 |
Rotigotine transdermal patch 2mg/24h(10cm2) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
314 |
Rotigotine transdermal patch 4mg/24h (20cm2) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
315 |
Rotigotine transdermal patch 6mg/24h (30cm2) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
316 |
Rotigotine transdermal patch 8mg/24h (40cm2) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
317 |
Rotigotine tts (test) |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
318 |
Rotigotine, extended-release microspheres |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
319 |
Routine transdermal oestrogen patch |
- |
- |
- |
- |
078 1件: 78 💬 |
320 |
Routine treatment of cd |
- |
- |
- |
- |
096 1件: 96 💬 |
321 |
Roxithromycin |
Roxithromycin |
1件: D01710 D01710 💬 |
- |
- |
046 2件: 46, 299 💬 |
322 |
Royal jelly |
Royal jelly |
1件: D09754 D09754 💬 |
- |
- |
049 1件: 49 💬 |
323 |
Rozanolixizumab |
Rozanolixizumab |
- |
- |
- |
011 3件: 11, 14, 63 💬 |
324 |
Rozerem |
- |
- |
- |
- |
006 1件: 6 💬 |
325 |
Satralizumab (ro5333787/enspryng /sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
326 |
Satralizumab (ro5333787/enspryng/sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
327 |
Satralizumab (ro5333787/sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
328 |
Satrazlizumab (ro5333787/ enspryng /sa237) |
- |
- |
- |
- |
013 1件: 13 💬 |
329 |
Sodium acid pyrophosphate sapp ror 28 food grade |
- |
- |
- |
- |
166 1件: 166 💬 |
330 |
Spd476 (mesalazine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
331 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
332 |
Standardized turmeric root extract |
Turmeric |
- |
- |
- |
299 1件: 299 💬 |
333 |
Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) |
Amoxicillin |
7件: D00229 D00229, D00276 D00276, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
063 1件: 63 💬 |
334 |
Tocilizumab (actemra or roactemra) |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
335 |
Tocilizumab [roactemra/actemra] |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 4件: 46, 51, 107, 331 💬 |
336 |
Tocilizumab [roactemra] |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
337 |
Tocilizumab infusion roacemtra (eu) |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
266 1件: 266 💬 |
338 |
Tocilizumab roche |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 2件: 46, 107 💬 |
339 |
Tolicizumab roche |
- |
- |
- |
- |
046 1件: 46 💬 |
340 |
Traditional chinese medicinal mixture (composed of roucongrong and adjuvant) |
- |
- |
- |
- |
006 1件: 6 💬 |
341 |
Tramadol with ropivacaine |
Ropivacaine |
4件: D01355 D01355, D04048 D04048, D08490 D08490, D08623 D08623 💬 |
OPRM1 6件: OPRM1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 6件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction |
070 1件: 70 💬 |
342 |
Transdermal flumazenil (added 4/2020) |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 1件: 6 💬 |
343 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere |
- |
- |
- |
- |
013 1件: 13 💬 |
344 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. |
- |
- |
- |
- |
013 1件: 13 💬 |
345 |
Uttr1147a/ro7021610 (active) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |